Cargando…

Linker Design Impacts Antibody-Drug Conjugate Pharmacokinetics and Efficacy via Modulating the Stability and Payload Release Efficiency

The development of antibody-drug conjugates (ADCs) has significantly been advanced in the past decade given the improvement of payloads, linkers and conjugation methods. In particular, linker design plays a critical role in modulating ADC stability in the systemic circulation and payload release eff...

Descripción completa

Detalles Bibliográficos
Autores principales:	Su, Dian, Zhang, Donglu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8262647/ https://www.ncbi.nlm.nih.gov/pubmed/34248637 http://dx.doi.org/10.3389/fphar.2021.687926

Ejemplares similares

Radiation Cleaved Drug-Conjugate Linkers Enable Local Payload Release
por: Quintana, Jeremy M., et al.
Publicado: (2022)

Antibody-Drug Conjugate Using Ionized Cys-Linker-MMAE as the Potent Payload Shows Optimal Therapeutic Safety
por: Wang, Yanming, et al.
Publicado: (2020)

Antibody–drug conjugates: Recent advances in payloads
por: Wang, Zhijia, et al.
Publicado: (2023)

Site-Specific Antibody Conjugation with Payloads beyond Cytotoxins
por: Zhou, Qun
Publicado: (2023)

Incorporation of Hydrophilic Macrocycles Into Drug-Linker Reagents Produces Antibody-Drug Conjugates With Enhanced in vivo Performance
por: Evans, Nick, et al.
Publicado: (2022)

Hydrophilic Auristatin Glycoside Payload Enables Improved Antibody-Drug Conjugate Efficacy and Biocompatibility
por: Satomaa, Tero, et al.
Publicado: (2018)

Antibody-Drug Conjugates Containing Payloads from Marine Origin
por: Cheng-Sánchez, Iván, et al.
Publicado: (2022)

Facile protein conjugation of platinum for light-activated cytotoxic payload release
por: Imberti, Cinzia, et al.
Publicado: (2021)

Antibody–Drug Conjugate Efficacy in Neuroblastoma: Role of Payload, Resistance Mechanisms, Target Density, and Antibody Internalization
por: Buongervino, Samantha, et al.
Publicado: (2021)

Chemotherapy payload of anti-insoluble fibrin antibody-drug conjugate is released specifically upon binding to fibrin
por: Fuchigami, Hirobumi, et al.
Publicado: (2018)

Antibody–drug conjugates: Recent advances in linker chemistry
por: Su, Zheng, et al.
Publicado: (2021)

Antitumor activity of a 5T4 targeting antibody drug conjugate with a novel payload derived from MMAF via C‐Lock linker
por: Shi, Baoying, et al.
Publicado: (2019)

Nicotinamide Phosphoribosyltransferase Inhibitor as a Novel Payload for Antibody–Drug Conjugates
por: Karpov, Alexei S., et al.
Publicado: (2018)

Payload diversification: a key step in the development of antibody–drug conjugates
por: Conilh, Louise, et al.
Publicado: (2023)

Disulfide re-bridging reagents for single-payload antibody-drug conjugates
por: King, Thomas A., et al.
Publicado: (2023)

Glutamic acid–valine–citrulline linkers ensure stability and efficacy of antibody–drug conjugates in mice
por: Anami, Yasuaki, et al.
Publicado: (2018)

Anti-PD-L1 immunoconjugates for cancer therapy: Are available antibodies good carriers for toxic payload delivering?
por: Zanello, Andrea, et al.
Publicado: (2022)

Improving the Serum Stability of Site-Specific Antibody Conjugates with Sulfone Linkers
por: Patterson, James T., et al.
Publicado: (2014)

Engineered hapten‐binding antibody derivatives for modulation of pharmacokinetic properties of small molecules and targeted payload delivery
por: Dengl, Stefan, et al.
Publicado: (2016)

Challenges and opportunities to develop enediyne natural products as payloads for antibody-drug conjugates
por: Adhikari, Ajeeth, et al.
Publicado: (2021)

Optimizing the enzymatic release of MMAE from isoDGR-based small molecule drug conjugate by incorporation of a GPLG-PABC enzymatically cleavable linker
por: Zambra, Marco, et al.
Publicado: (2023)

Decoupling stability and release in disulfide bonds with antibody-small molecule conjugates
por: Pillow, Thomas H., et al.
Publicado: (2017)

Antibody-drug conjugates with dual payloads for combating breast tumor heterogeneity and drug resistance
por: Yamazaki, Chisato M., et al.
Publicado: (2021)

Antibody-Drug Conjugates in Solid Tumor Oncology: An Effectiveness Payday with a Targeted Payload
por: Kondrashov, Aleksei, et al.
Publicado: (2023)

Antibody-drug conjugates: recent advances in conjugation and linker chemistries
por: Tsuchikama, Kyoji, et al.
Publicado: (2016)

Optimization of the Linker Length of Mannose-Cholesterol Conjugates for Enhanced mRNA Delivery to Dendritic Cells by Liposomes
por: Wang, Fazhan, et al.
Publicado: (2018)

Automated linkage of proteins and payloads producing monodisperse conjugates
por: Dovgan, Igor, et al.
Publicado: (2020)

Sulfatase-cleavable linkers for antibody-drug conjugates
por: Bargh, Jonathan D., et al.
Publicado: (2020)

Peroxide-cleavable linkers for antibody–drug conjugates
por: Ashman, Nicola, et al.
Publicado: (2023)

On the use of DNA as a linker in antibody-drug conjugates: synthesis, stability and in vitro potency
por: Dovgan, Igor, et al.
Publicado: (2020)

A Novel NAMPT Inhibitor-Based Antibody–Drug Conjugate Payload Class for Cancer Therapy
por: Böhnke, Niels, et al.
Publicado: (2022)

Site-Dependent Degradation of a Non-Cleavable Auristatin-Based Linker-Payload in Rodent Plasma and Its Effect on ADC Efficacy
por: Dorywalska, Magdalena, et al.
Publicado: (2015)

Near-Infrared-Induced Heating of Confined Water in Polymeric Particles for Efficient Payload Release
por: Viger, Mathieu L., et al.
Publicado: (2014)

Microbubble–liposome conjugate: Payload evaluation of potential theranostic vehicle
por: Malik, Ritu, et al.
Publicado: (2016)

Development of Photoremovable Linkers as a Novel Strategy to Improve the Pharmacokinetics of Drug Conjugates and Their Potential Application in Antibody–Drug Conjugates for Cancer Therapy
por: Johan, Audrey Nathania, et al.
Publicado: (2022)

Linkers: An Assurance for Controlled Delivery of Antibody-Drug Conjugate
por: Sheyi, Rotimi, et al.
Publicado: (2022)

Lysosomal-Cleavable Peptide Linkers in Antibody–Drug Conjugates
por: Balamkundu, Seetharamsing, et al.
Publicado: (2023)

Single Mutation on Trastuzumab Modulates the Stability of Antibody–Drug Conjugates Built Using Acetal-Based Linkers and Thiol-Maleimide Chemistry
por: Ferhati, Xhenti, et al.
Publicado: (2022)

An Efficient Conjugation Approach for Coupling Drugs to Native Antibodies via the Pt(II) Linker Lx for Improved Manufacturability of Antibody–Drug Conjugates
por: Merkul, Eugen, et al.
Publicado: (2021)

Quantification of intracellular payload release from polymersome nanoparticles
por: Scarpa, Edoardo, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_q6ismj47jl6mdio2vvs0t6vmgu